HYPR Company Profile and Key Details

HYPR has shown mixed momentum, gaining 17.65% over the past week and -7.69% over the past quarter, though year-to-date performance is up 22.54%. Short-term trend indicators are bearishly aligned (SMA20 0.8%, SMA50 2.68%, SMA200 3.47%). The stock’s 14-day RSI is 50.52 (neutral), while the ATR of 0.08 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -49.1% below its high and over 112.13% above its low. Average 10-day trading volume of 401.16 thousand shares is below the 3-month average of 962.23 thousand, indicating normal recent market interest.

Hyperfine, Inc. generated EPS of -$0.52 over the past year. Five-year average earnings growth is 11.81%. The latest quarter delivered EPS of -$0.09. The next quarter is forecast at -$0.08. Next year's EPS is expected at $2.56. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $2.50 to $2.00. The high target offers 216.46% upside. The low target suggests 153.16% downside. The mean target is $2.25. This offers 184.81% upside. Hyperfine, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 06, 2026, missed forecasts by 0.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in May 13, 2025.

Hyperfine, Inc. has 90.99 million shares outstanding. The public float is 86.42 million shares, elevated short interest at 3.33% of float. This equals 2.96 million shares. The short ratio is 3.19 days. Institutional investors hold 16.28% of the float. Insiders own 4.81%. HC Sponsor LLC holds 1.25 million shares, ROTHBERG JONATHAN M has 885.71 thousand shares and TEISSEYRE THOMAS has 671.26 thousand shares. Over the past six months, insider transactions show net selling. They sold 75.16 thousand shares across 6 transactions.

Hyperfine, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.62. This means the shares are trading below this model’s fair value.

The stock is currently trading near its 52-week low $0.78 and $2.22. With a market capitalization of about $66.23 million, Hyperfine, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.41). Key stats such as the average daily volume over the past year has been around 983.85 thousand shares, volume is running light vs its 52-week average. Headquartered in Guilford, CT, Hyperfine, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Maria Degois Sainz, the company employs approximately 102 people and listed since January 28, 2021. Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.

Hyperfine, Inc. trades at a P/E ratio of -2.06, slightly below the S&P 500 average, with a price-to-sales ratio of 4.01 and a price-to-book ratio of 2.14 suggesting the stock is closer to book value. The P/FCF stands at -2.41, also below market averages.

Hyperfine, Inc. (NASDAQ:HYPR) shares are up 22.54% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Hyperfine, Inc. trading at a premium to the broader market with a P/E of -2.06. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $2.80, suggesting 256.05% upside. Our AI forecast model points to short-term weakness (-7.17% over two weeks), a medium-term fall (-47.86% over three months), and a longer-term gain (123.8% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Hyperfine, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -7.17%, with price expected at $0.73 by September 23, 2026, within a range of $0.70 to $0.76 3-Month Outlook: Projected fall of -47.86%, reaching $0.41 by December 08, 2026, with a range of $0.33 to $0.48. 1-Year Outlook: Projected gain of 123.8%, with price at $1.76 by September 09, 2027, within a range of $0.00 to $0.19.